Aitian Li

962 total citations · 1 hit paper
11 papers, 665 citations indexed

About

Aitian Li is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Aitian Li has authored 11 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Aitian Li's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (4 papers) and Immune cells in cancer (3 papers). Aitian Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (4 papers) and Immune cells in cancer (3 papers). Aitian Li collaborates with scholars based in China. Aitian Li's co-authors include Yi Zhang, Ying Wang, Yang Li, Li Yang, Qingyang Lei, Weina Yu, Jinbo Liu, Zhenqiang Sun, Jingyao Lian and Feng Li and has published in prestigious journals such as Frontiers in Immunology, Advanced Science and Signal Transduction and Targeted Therapy.

In The Last Decade

Aitian Li

9 papers receiving 662 citations

Hit Papers

Intratumoral microbiota: roles in cancer initiation, deve... 2023 2026 2024 2025 2023 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aitian Li China 7 328 265 259 98 80 11 665
Yaoyao Shi China 12 392 1.2× 489 1.8× 434 1.7× 135 1.4× 76 0.9× 18 980
Martina Di Modica Italy 12 444 1.4× 588 2.2× 249 1.0× 189 1.9× 90 1.1× 15 972
Sabina Kaczanowska United States 8 361 1.1× 319 1.2× 524 2.0× 136 1.4× 68 0.8× 11 870
Elisabetta Bolli Italy 14 200 0.6× 271 1.0× 235 0.9× 105 1.1× 94 1.2× 28 574
Bhalchandra Mirlekar United States 11 458 1.4× 278 1.0× 643 2.5× 94 1.0× 59 0.7× 15 973
Loryn Holokai United States 7 333 1.0× 142 0.5× 128 0.5× 91 0.9× 85 1.1× 12 528
Jun-Ting Cheng China 11 345 1.1× 443 1.7× 270 1.0× 210 2.1× 69 0.9× 15 852
Aizhi Zhao China 13 196 0.6× 297 1.1× 196 0.8× 53 0.5× 103 1.3× 23 633
Jenny Sprooten Belgium 10 317 1.0× 248 0.9× 381 1.5× 88 0.9× 112 1.4× 12 649
Danielle M. Lussier United States 6 534 1.6× 274 1.0× 518 2.0× 162 1.7× 199 2.5× 8 990

Countries citing papers authored by Aitian Li

Since Specialization
Citations

This map shows the geographic impact of Aitian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aitian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aitian Li more than expected).

Fields of papers citing papers by Aitian Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aitian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aitian Li. The network helps show where Aitian Li may publish in the future.

Co-authorship network of co-authors of Aitian Li

This figure shows the co-authorship network connecting the top 25 collaborators of Aitian Li. A scholar is included among the top collaborators of Aitian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aitian Li. Aitian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Yunhan, Weina Yu, Xinxin Wang, et al.. (2025). TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells. Advanced Science. 13(5). e06995–e06995. 1 indexed citations
2.
4.
Li, Yang, Aitian Li, Dan Wang, et al.. (2024). Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer. Drug Resistance Updates. 78. 101175–101175. 14 indexed citations
5.
Li, Aitian, et al.. (2024). A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues. Scientific Data. 11(1). 1064–1064. 3 indexed citations
6.
Li, Yang, Aitian Li, Ying Wang, & Yi Zhang. (2023). Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduction and Targeted Therapy. 8(1). 35–35. 250 indexed citations breakdown →
7.
Li, Yang, Aitian Li, Qitai Zhao, et al.. (2021). Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer. Frontiers in Cell and Developmental Biology. 9. 596484–596484. 9 indexed citations
8.
Wang, Zhoutao, Guilong Lu, Qibin Wu, et al.. (2021). Isolating QTL controlling sugarcane leaf blight resistance using a two-way pseudo-testcross strategy. The Crop Journal. 10(4). 1131–1140. 15 indexed citations
9.
Wang, Dan, Weina Yu, Jingyao Lian, et al.. (2020). Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients. Journal of Hematology & Oncology. 13(1). 68–68. 56 indexed citations
10.
Yang, Li, Aitian Li, Qingyang Lei, & Yi Zhang. (2019). Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Journal of Hematology & Oncology. 12(1). 125–125. 156 indexed citations
11.
Wang, Dan, Yang Li, Weina Yu, et al.. (2019). Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. Journal for ImmunoTherapy of Cancer. 7(1). 215–215. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026